(Q51346924)

4 April 2018

title

The effect of propranolol on anxiety. (English)

1 reference

4 April 2018

author name string

K L Granville-Grossman

series ordinal

1

1 reference

4 April 2018

P Turner

series ordinal

2

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 April 1966

1 reference

4 April 2018

published in

The Lancet

1 reference

4 April 2018

volume

1

1 reference

4 April 2018

issue

7441

1 reference

4 April 2018

page(s)

788-790

1 reference

4 April 2018

Clinical experiences with propranolol

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

Action of sympathomimetic and allied amines on the central nervous system of the chicken

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

USE OF PROPRANOLOL IN ANGINA PECTORIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

Some effects of propranolol on the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

Orthostatic ECG Changes and the Adrenergic Beta-receptor Blocking Agent, Propranolol (Inderal)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

Myocardial vascular reactivity after beta-adrenergic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

BETA-ADRENERGIC RECEPTOR BLOCKADE IN CARDIAC ARRHYTHMIAS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

PHYSIOLOGICAL AND CLINICAL EFFECTS OF AMYLOBARBITONE SODIUM THERAPY IN PATIENTS WITH ANXIETY STATES.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2866%2991863-0

7 January 2021

10.1016/S0140-6736(66)91863-0

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018